MX2016007202A - Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal. - Google Patents

Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal.

Info

Publication number
MX2016007202A
MX2016007202A MX2016007202A MX2016007202A MX2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A MX 2016007202 A MX2016007202 A MX 2016007202A
Authority
MX
Mexico
Prior art keywords
pam
terminal amidation
peptidylglycine alpha
monooxigenase
amidating
Prior art date
Application number
MX2016007202A
Other languages
English (en)
Inventor
Georg Tiefenthaler
Eike Hoffmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2016007202A publication Critical patent/MX2016007202A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y403/00—Carbon-nitrogen lyases (4.3)
    • C12Y403/02—Amidine-lyases (4.3.2)
    • C12Y403/02005—Peptidylamidoglycolate lyase (4.3.2.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un aspecto que se reporta en la presente es un método para la amidación C-terminal in vivo de un polipéptido se caracteriza en que tanto el polipéptido (se amidará) y la monooxigenasa alfa-amidante de peptidilglicina (PAM) de humano se expresa complementaria y recombinantemente en una célula de mamífero.
MX2016007202A 2013-12-20 2014-12-10 Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal. MX2016007202A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199222 2013-12-20
PCT/EP2014/077143 WO2015091131A1 (en) 2013-12-20 2014-12-10 Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidation

Publications (1)

Publication Number Publication Date
MX2016007202A true MX2016007202A (es) 2016-07-21

Family

ID=49885043

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007202A MX2016007202A (es) 2013-12-20 2014-12-10 Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal.

Country Status (10)

Country Link
US (1) US20160333386A1 (es)
EP (1) EP3083662A1 (es)
JP (1) JP2017507645A (es)
KR (1) KR20160098278A (es)
CN (1) CN105793278A (es)
BR (1) BR112016012325A2 (es)
CA (1) CA2928927A1 (es)
MX (1) MX2016007202A (es)
RU (1) RU2016129516A (es)
WO (1) WO2015091131A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021170752A1 (en) * 2020-02-26 2021-09-02 Pam Theragnostics Gmbh Methods for determining peptidylglycine alpha-amidating monooxygenase (pam) and its use for diagnostic purpose
KR20220146538A (ko) * 2020-02-26 2022-11-01 페아엠 테라그노스틱스 게엠베하 치료 목적을 위한 펩티딜글리신 알파-아미드화 모노옥시게나제 (pam)의 용도
WO2025133225A1 (en) * 2023-12-22 2025-06-26 Pam Theragnostics Gmbh Pharmaceutical combination of peptide-gly and peptidylglycine alpha-amidating monooxygenase (pam)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8660701A1 (es) * 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US8008453B2 (en) * 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
CN102666570B (zh) * 2009-12-01 2015-12-02 诺沃—诺迪斯克有限公司 新的肽基α-羟基甘氨酸α-酰胺化裂合酶

Also Published As

Publication number Publication date
CN105793278A (zh) 2016-07-20
BR112016012325A2 (pt) 2017-09-26
RU2016129516A (ru) 2018-01-25
CA2928927A1 (en) 2015-06-25
EP3083662A1 (en) 2016-10-26
US20160333386A1 (en) 2016-11-17
KR20160098278A (ko) 2016-08-18
JP2017507645A (ja) 2017-03-23
WO2015091131A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
IN2015DN02032A (es)
AU336097S (en) Open vessel sealing forceps
MY186864A (en) Fusion immunomodulatory proteins and methods for making same
MX371272B (es) El péptido mots3 derivado de mitocondrias regula el metabolismo y la supervivencia celular.
UA115120C2 (uk) Спосіб застосування химерного поліпептиду фактора ix
IL216680A0 (en) Growth hormone polypeptide and methods of making and using same
MX346786B (es) Polipeptidos de relaxina modificados y sus usos.
IN2014DN06200A (es)
CR20140586A (es) Celulas para producir iduronato-2-sulfatasa recombinante
NZ603196A (en) Methods of use of soluble cd24 for therapy of rheumatoid arthritis
PH12014502537A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
SG11201601262QA (en) CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING α-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES
MX2016000393A (es) Modificaciones de proteinas quimioenzimaticas de lisina utilizando transglutaminasa microbiana.
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.
MX349544B (es) Extractos de maesa japonica y métodos de uso.
EA201290541A1 (ru) Модифицированные бычьи соматотропиновые полипептиды и их применение
MX2020012356A (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.
EA201290542A1 (ru) Модифицированные свиные соматотропиновые полипептиды и их применение
NZ594198A (en) Neil3 peptides and vaccines including the same
MX2016007202A (es) Uso de monooxigenasa alfa-amidante de peptidilglicina (pam) para amidacion c-terminal.
AU329039S (en) Maternity shorts
IL289372A (en) A process for recycling organic matter to produce methane and/or hydrogen
IN2013MU02527A (es)
IN2015DN02873A (es)
SG11201600872UA (en) Means and methods for the generation of mammalian producer cells for the production of recombinant proteins